What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Myocardial infarction
- Cardiology
David A. Morrow mostly deals with Internal medicine, Cardiology, Myocardial infarction, TIMI and Acute coronary syndrome.
His study brings together the fields of Endocrinology and Internal medicine.
His research integrates issues of Stroke, Surgery and Hazard ratio in his study of Myocardial infarction.
His work in TIMI tackles topics such as Pravastatin which are related to areas like Lipoprotein.
The various areas that David A. Morrow examines in his Acute coronary syndrome study include Biochemical markers, Cardiac troponin, Enoxaparin sodium, Myocardial ischemia and Risk factor.
The Heart failure study which covers Intensive care medicine that intersects with Biomarker.
His most cited work include:
- 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction (3161 citations)
- Universal definition of myocardial infarction. (2105 citations)
- C-Reactive Protein Levels and Outcomes after Statin Therapy (1905 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Cardiology, Myocardial infarction, TIMI and Acute coronary syndrome.
His research on Internal medicine often connects related areas such as Surgery.
The concepts of his Myocardial infarction study are interwoven with issues in Ischemia and Hazard ratio.
His TIMI research includes elements of ST segment, Fibrinolysis, Framingham Risk Score and Ranolazine.
His Acute coronary syndrome study integrates concerns from other disciplines, such as Diabetes mellitus and Placebo.
His Heart failure research is multidisciplinary, incorporating elements of Biomarker, Valsartan and Intensive care medicine.
He most often published in these fields:
- Internal medicine (80.03%)
- Cardiology (66.40%)
- Myocardial infarction (40.61%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (80.03%)
- Cardiology (66.40%)
- Heart failure (16.40%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Cardiology, Heart failure, TIMI and In patient.
His work in Myocardial infarction, Biomarker, Stroke, Acute coronary syndrome and Randomized controlled trial are all subfields of Internal medicine research.
He studies Troponin which is a part of Myocardial infarction.
In his study, Proportional hazards model is strongly linked to Renal function, which falls under the umbrella field of Cardiology.
The Heart failure study combines topics in areas such as Diabetes mellitus, Relative risk, Framingham Risk Score and Hazard ratio.
His TIMI study combines topics from a wide range of disciplines, such as Clinical trial, Peripheral artery disease, Drug discontinuation, Study drug and Secondary prevention.
Between 2018 and 2021, his most popular works were:
- Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure (302 citations)
- COVID-19 for the Cardiologist: Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies (120 citations)
- Epidemiology of Shock in Contemporary Cardiac Intensive Care Units. (52 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Myocardial infarction
- Gene
His main research concerns Internal medicine, Cardiology, Myocardial infarction, Heart failure and Emergency medicine.
His Internal medicine and Stroke, TIMI, Acute coronary syndrome, Hazard ratio and Biomarker investigations all form part of his Internal medicine research activities.
His study in the field of Conventional PCI is also linked to topics like In patient.
His biological study focuses on Troponin.
His Heart failure research is multidisciplinary, relying on both Enalapril and Renal function.
His research on Emergency medicine also deals with topics like
- Coronary care unit which is related to area like Medical diagnosis, Severity of illness, Framingham Risk Score, Intensive care unit and Intensive care medicine,
- Retrospective cohort study, which have a strong connection to Quality of life,
- Respiratory failure and related Incidence,
- Cardiogenic shock that connect with fields like Mortality rate.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
